Navigation Links
OphthaliX Reports First Quarter 2012 Financial Results
Date:5/15/2012

SALT LAKE CITY, May 15, 2012 /PRNewswire/ -- OphthaliX (OTCBB: OPLI) today reported its financial and operating results for the quarter ended March 31, 2012. OphthaliX is an advanced clinical-stage biopharmaceutical company focused on developing therapeutic products for the treatment of ophthalmic disorders.  Our drug, CF101 (known generically as IB-MECA), is being developed to treat three ophthalmic indications: dry eye syndrome; glaucoma and uveitis. We are currently: (i) conducting a Phase III trial with respect to the development of CF101 for dry eye syndrome, under an Investigational New Drug, or IND, application with the United States Food and Drug Administration, or FDA; (ii) conducting a Phase II trial with respect to the development of CF101 for the treatment of glaucoma; and (iii) preparing for Phase II study of the development of CF101 for uveitis.

Prof. Pnina Fishman, interim CEO and Chairman of OphthaliX commented: "We continue to make good progress on the development of CF101 for the ongoing ophthalmic indications with both the Phase 3 Dry Eye and the Phase 2 Glaucoma studies."

For the period from June 27, 2011 (inception date of Eyefite) to March 31, 2012, we did not generate any revenues from operations.  Expenses during the quarter ended March 31, 2012, were $710,000 with a finance expense of $2,114,000 for a net loss of $2,824,000. Expenses for the period mentioned above consisted of research and development activities of $508,000 and general and administrative expenses of $202,000.  These expenses were mainly due to professional, legal and accounting fees relating to our reporting requirements.  The finance expenses were mainly due to a change in the fair value of derivatives in the amount of $2,116,000.  There were no comparable expenses during the prior year quarter ended March 31, 2011. As of March 31, 2012 we had $2,467,000 in cash.  We believe that such funds will be suf
'/>"/>

SOURCE OphthaliX Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. Spherix Reports Second Quarter Earnings
3. Tapestry Reports Second Quarter 2007 Results
4. Callisto Reports on Second-Quarter 2007 Milestones
5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
6. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
7. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
8. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
9. Biopure Reports on Meeting with the FDA
10. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
11. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , July 29, 2015 The U.S. ... balloon device called the ReShape Integrated Dual Balloon System, ... and surgery for people with obesity and one or ... Metabolic and Bariatric Surgery (ASMBS), the nation,s largest organization ... gratified that after careful review the FDA has approved ...
(Date:7/29/2015)... , July 29, 2015 Alvarado ... 23, called the Alvarado Spine & Joint Institute. ... and rehabilitation, focusing on spinal surgery and joint ... patient care takes a patient experience-focused approach. For ... they feel comfortable in, rather than patient gowns. ...
(Date:7/29/2015)... Uno studio clinico di un centro ... probiotico L. reuteri di Nutraceutix arricchisce ... intestinale di fattori proteici che aumentano la secrezione ... ceppo di L. reuteri di Nutraceutix ... di somministrazione brevettato BIO- tract ® che protegge ...
Breaking Medicine Technology:American Society for Metabolic and Bariatric Surgery Views New Balloon Device For Obesity As Bridge Between Medications And Bariatric Surgery 2American Society for Metabolic and Bariatric Surgery Views New Balloon Device For Obesity As Bridge Between Medications And Bariatric Surgery 3The Alvarado Spine & Joint Institute Opens July 30 in San Diego 2È stato clinicamente dimostrato che il probiotico L. reuteri di Nutraceutix regola il metabolismo insulinico intestinale 2
... , NEWNAN, ... specialty surface treatments for medical devices and of specialty implants, ... Gordy, will give an opening address for the Technology Parade ... Israel. "We must leave the era of petty self-interest ...
... , PLEASANTON, Calif., Dec. 1 The ... Microchip Biotechnologies, Inc. has been taken up by Howard ... 30 years of experience creating and managing life science ... business development, sales and customer service operations as the ...
Cached Medicine Technology:CeloNova BioSciences CEO Urges More Heart, More Passion, More Honesty, and All Urgency in Developing Medical Devices 2Howard Goldstein Joins Microchip Biotechnologies, Inc. as Executive Vice President 2
(Date:7/29/2015)... Washington, DC (PRWEB) , ... July 29, 2015 , ... ... a company rebrand, changing its name to Rock the Reformer ® by Potomac Pilates. ... website - http://www.RockTheReformer.com . Rock the Reformer ® by Potomac Pilates will continue ...
(Date:7/29/2015)... ... July 29, 2015 , ... The report “Atherosclerosis ... Atherosclerosis. Atherosclerosis is a slow, progressive disease that may start in childhood. The ... and best-in-class products. Complete report on Atherosclerosis Pipeline with 78 market data tables ...
(Date:7/29/2015)... ... July 29, 2015 , ... The healthcare analytics market ... and region. Factors such as the rising pressure to curb healthcare costs, big ... in venture capital investments are driving market growth. Check 149 data tables & ...
(Date:7/29/2015)... ... July 29, 2015 , ... According to The Spirits ... gene which is directly responsible for stimulating and perpetuating alcohol use disorders. Humans have ... entitled Proceedings of the National academy of Sciences, and has given researchers inklings to ...
(Date:7/29/2015)... ... July 29, 2015 , ... According to the Miami Herald ... addiction and mental health disorders. Acu-detox may begin taking off in the South Florida ... and alcohol addiction. Although acupuncture is not a new practice, it is not widely ...
Breaking Medicine News(10 mins):Health News:Same Great Pilates Studio, New Brand - Rock the Reformer 2Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 2Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 3Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 4Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 5Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 2Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 3Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 2Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 3
... a waiting list, can reduce problems with recurring low back ... Many people suffer with low back pain, and most ... find that their work, everyday and leisure activities are limited ... treatment, it is important that the pain be treated at ...
... Food and Drug Administration (FDA) approval of a brain aneurysm ... Jefferson Hospital for Neuroscience (JHN) to offer advanced ... otherwise have limited, effective options. "With this FDA approval, ... tool to block and shrink these types of aneurysms, saving ...
... Indiana soon will partner with colleagues in Ohio ... working across state lines to advance research on ... program, supported by the Indiana Clinical and Translational ... across the region, including Indiana University Health Riley ...
... Prozac: new drug offers hope for depression ... from depression, and though the symptoms might be ... incompletely understood. Research suggests that aberrant signaling by ... its receptor TrkB, may contribute to anxiety and ...
... Vancouver,s Downtown Eastside dropped by 35 per cent after ... facility, according a new study by researchers at the ... for Excellence in HIV/AIDS. Published today in The ... assess the impact of supervised injection sites on overdose ...
... Psychologists are offering new insight and solutions ... with the environmental, economic and health impacts already taking ... issue of American Psychologist , the American Psychological ... for and in many cases is already affecting ...
Cached Medicine News:Health News:Immediate treatment can alleviate future back problems 2Health News:FDA approval of brain aneurysm device gives Jefferson neurosurgeons another life-saving tool 2Health News:Children's doctors team up across state lines to fight disease 2Health News:JCI online early table of contents: April 18, 2011 2Health News:JCI online early table of contents: April 18, 2011 3Health News:JCI online early table of contents: April 18, 2011 4Health News:JCI online early table of contents: April 18, 2011 5Health News:JCI online early table of contents: April 18, 2011 6Health News:JCI online early table of contents: April 18, 2011 7Health News:Overdose deaths down 35 percent after opening of Vancouver's supervised injection site: UBC-BC-CfE study 2Health News:Climate change psychology: Coping and creating solutions 2Health News:Climate change psychology: Coping and creating solutions 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: